Navigation Links
New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS

PALO ALTO, Calif., March 3 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today the release of two new evaporative light scattering detectors (ELSD) for conventional and high speed liquid chromatography. With their universal response, full gradient and solvent compatibility, and excellent baseline stability, Varian ELSDs possess key advantages over conventional UV and RI detectors for busy pharmaceutical and analytical laboratories. In addition, they complement electrospray detection in LC/MS (Liquid Chromatography/Mass Spectrometry) for compounds that are difficult to ionize.

With the capability to deliver sub-ambient evaporation down to 10 degrees Celsius, the new Varian 385-LC provides maximum sensitivity for compounds with significant volatility below 30 degrees Celsius, giving it the widest application range of all ELSDs. The new Varian 380-LC is the instrument of choice for non-volatile compounds, including analyses where elevated temperature offers higher sensitivity.

Both instruments offer unrivalled flexibility and sensitivity, delivering a universal response down to the low nanogram range for trace analysis. Real time gas management eliminates solvent effects for constant response across a gradient. Digital data collection enables the detectors to be interfaced with multi-vendor analysis platforms and removes the need for analog to digital interfaces. The new instruments allow chromatographers to save time and improve productivity with on-the-fly adjustment of light source intensity for sample mixtures with a wide concentration range. Excellent reproducibility (plus or minus < 2%), greatly enhances productivity. Fast data output rates and extremely low dispersion are ideal for high speed LC, an increasingly important analytical technique.

"These programmable ELSDs provide chemists with unrivalled control of an analysis in real time," says Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "Varian's new 380-LC family of detectors bring sensitive and accurate detection capability to an even wider range of applications."

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site:

For more technical information about Varian's Scientific Instruments, please visit

For More Information, Contact:

Public Relations

Varian, Inc.


SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
2. Varian, Inc. Reports First Quarter 2008 Results
3. Roche Extends Tender Offer for Ventana
4. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
5. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
6. Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission
7. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
8. ChemAxon and Agilent Technologies Sign Agreement Extending JChem Integration With Kalabie Electronic Lab Notebook
9. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
10. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
11. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):